Biobanking sales are projected to grow at a CAGR of 7.25% taking the value of the industry to close to $88 billion by 2032. The industry has been on an [...]
How to Encourage Biospecimen Donation As scientists continue to delve deeper into precision medicine, the need for biodiversity in biospecimens becomes even more imperative. While high-quality biospecimens are essential components [...]
The future of modern medicine hugely relies on biobanking; biobanks collect, preserve, annotate, and disseminate biological samples (tissues, blood, nucleic acids) and their related metadata which are then used to [...]
CloudLIMS participated in the A2LA Tech Forum 2022 held from April 3-6, 2022 in Chantilly, Virginia. More than 200 attendees from various sectors such as automotive, cannabis, environmental, life sciences, [...]
CloudLIMS is excited to participate in the IBS 2022 Virtual Symposium to be held on February 22, 2022. Our COO, Shonali Paul, is delivering a talk titled “Regulatory Challenges in [...]
Artificial intelligence (AI) is radically transforming biobanking and modern research. Traditional methods of harnessing data and manual decision-making processes have been replaced with AI-driven algorithms and machine learning. Biospecimen collection [...]
Biobanks play a pivotal role in ensuring the success of research and clinical trials geared towards a better understanding of diseases and the formulation of better drug therapies. Biobanks collect, [...]
Support
Tutorials
+1-302-789-0447
support@cloudlims.com
by 
